PanGen Biotech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,705	3,756	1,430	45.4	838.28	8,901
Short-Term Investments	9,002	10,048	10,002	149.24	2	15,199
Cash & Short-Term Investments	12,707	13,804	11,432	194.64	840.28	24,100
Cash Growth	14.95%	20.74%	5773.48%	-76.84%	-96.51%	28.95%
Accounts Receivable	2,963	1,574	2,959	2,208	689.81	1,089
Other Receivables	257.46	116.77	51.8	8.54	221.29	241.03
Receivables	3,220	1,690	3,261	2,330	974.1	1,393
Inventory	7,420	7,240	6,001	6,925	6,630	4,373
Prepaid Expenses	25.6	20.7	53.96	58.91	71.41	21.39
Other Current Assets	429.15	385.81	20.35	333.62	60.91	1,267
Total Current Assets	23,801	23,140	20,768	9,843	8,576	31,154
Property, Plant & Equipment	6,261	5,986	5,805	6,240	6,608	6,748
Long-Term Investments	0	0	0	0	0	-0
Other Intangible Assets	1,061	1,065	785.13	879.93	269.63	313.41
Long-Term Deferred Charges	1,803	1,967	2,622	3,278	3,933	4,589
Other Long-Term Assets	531.05	542.29	564.14	501.5	1,287	473.47
Total Assets	33,457	32,700	30,545	20,741	20,674	43,277
Accounts Payable	391.55	157.84	423.33	298.82	255.48	381.91
Accrued Expenses	190.15	186.02	-	-	-	-
Short-Term Debt	1,002	962.05	816.3	2,014	-	18,692
Current Portion of Leases	1.27	0.39	1.84	1.69	1.56	1.43
Other Current Liabilities	1,162	1,440	1,657	3,396	872.49	811.14
Total Current Liabilities	2,746	2,746	2,899	5,711	1,130	19,886
Long-Term Leases	6.42	-	0.39	2.24	3.93	5.49
Pension & Post-Retirement Benefits	-	-	2,707	2,432	2,114	2,171
Other Long-Term Liabilities	30	30	30	30	206.41	116.22
Total Liabilities	2,783	2,776	5,636	8,175	3,454	22,179
Common Stock	6,747	6,747	6,449	5,339	5,339	5,336
Additional Paid-In Capital	10,779	10,779	67,712	57,402	57,402	57,371
Retained Earnings	12,448	11,697	-49,953	-50,876	-46,210	-42,062
Comprehensive Income & Other	700.82	700.82	700.82	700.82	688.64	452.86
Total Common Equity	30,675	29,924	24,909	12,566	17,219	21,098
Shareholders' Equity	30,675	29,924	24,909	12,566	17,219	21,098
Total Liabilities & Equity	33,457	32,700	30,545	20,741	20,674	43,277
Total Debt	1,010	962.44	818.54	2,018	5.49	18,699
Net Cash (Debt)	11,697	12,841	10,614	-1,823	834.79	5,402
Net Cash Growth	14.66%	20.99%	-	-	-84.55%	1760.05%
Net Cash Per Share	856.74	953.30	922.27	-170.60	78.21	528.69
Filing Date Shares Outstanding	13.65	13.49	12.9	10.68	10.68	10.67
Total Common Shares Outstanding	13.65	13.49	12.9	10.68	10.68	10.67
Working Capital	21,055	20,394	17,869	4,132	7,447	11,267
Book Value Per Share	2247.70	2217.56	1931.18	1176.85	1612.67	1976.95
Tangible Book Value	29,613	28,859	24,124	11,686	16,950	20,784
Tangible Book Value Per Share	2169.92	2138.62	1870.31	1094.44	1587.42	1947.58
Land	1,174	1,174	1,174	1,174	1,174	1,174
Buildings	3,909	3,909	3,909	3,909	3,909	3,909
Machinery	12,520	12,382	11,766	11,545	11,434	10,381
Construction In Progress	204.3	112.7	-	125.36	-	332.66